TrialClinical cancer research : an official journal of the American Association for Cancer Research2011

Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group.

Judith G Villablanca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.